- Consensus Rating
- Reduce
- Rating Score
- 1.9
- Ratings Breakdown
- 0 Buy Ratings, 7 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $58.25 (14.0% Downside)
About Solventum
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Read More
Recent Analyst Ratings